Community Bank’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-497
Closed -$56K – 455
2021
Q4
$56K Sell
497
-246
-33% -$29.7K 0.01% 302
2021
Q3
$93K Sell
743
-237
-24% -$30.5K 0.01% 281
2021
Q2
$133K Hold
980
– – 0.02% 259
2021
Q1
$133K Sell
980
-112
-10% -$16.8K 0.02% 257
2020
Q4
$154K Sell
1,092
-110
-9% -$14.1K 0.02% 247
2020
Q3
$134K Sell
1,202
-167
-12% -$18.7K 0.02% 249
2020
Q2
$153K Buy
+1,369
New +$135K 0.03% 243
2017
Q2
– Sell
-119
Closed -$8K – 571
2017
Q1
$8K Hold
119
– – ﹤0.01% 364
2016
Q4
$7K Buy
+119
New +$7.35K ﹤0.01% 391

Other funds holding XBI

Community Bank's XBI Position: Q1 2022 in Review

Community Bank sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2022, closing a stake of 497 shares — an estimated $56K sold.

Community Bank first reported a position in XBI in Q4 2016 and held it in 9 quarters. The position peaked at $154K in Q4 2020. 702 funds tracked by Wall St. Rank hold XBI as of Q1 2022.

  • Community Bank reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2022 after selling out during the quarter.
  • Community Bank sold 497 State Street SPDR S&P Biotech ETF shares in Q1 2022, an estimated $56K.
  • Community Bank first reported a position in State Street SPDR S&P Biotech ETF in Q4 2016 and held it in 9 quarters.
  • Community Bank's State Street SPDR S&P Biotech ETF position peaked at $154K in Q4 2020.
  • 702 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2022.

Based on Community Bank's 13F filing for Q1 2022, filed 5 May 2022.